Mosaic Family Wealth LLC trimmed its position in shares of Express Scripts Holding (NASDAQ:ESRX) by 19.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,806 shares of the company’s stock after selling 1,658 shares during the period. Mosaic Family Wealth LLC’s holdings in Express Scripts were worth $508,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also recently made changes to their positions in the company. Van ECK Associates Corp raised its holdings in shares of Express Scripts by 5.1% during the third quarter. Van ECK Associates Corp now owns 506,511 shares of the company’s stock worth $32,072,000 after acquiring an additional 24,728 shares in the last quarter. Victory Capital Management Inc. raised its holdings in shares of Express Scripts by 12.5% during the third quarter. Victory Capital Management Inc. now owns 35,421 shares of the company’s stock worth $2,243,000 after acquiring an additional 3,940 shares in the last quarter. LMR Partners LLP purchased a new stake in shares of Express Scripts during the third quarter worth $3,230,000. Polianta Ltd raised its holdings in shares of Express Scripts by 38.9% during the fourth quarter. Polianta Ltd now owns 20,700 shares of the company’s stock worth $1,545,000 after acquiring an additional 5,800 shares in the last quarter. Finally, Zeke Capital Advisors LLC raised its holdings in shares of Express Scripts by 85.4% during the third quarter. Zeke Capital Advisors LLC now owns 12,347 shares of the company’s stock worth $782,000 after acquiring an additional 5,688 shares in the last quarter. Institutional investors and hedge funds own 89.08% of the company’s stock.
In related news, VP Christine Houston sold 10,104 shares of Express Scripts stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $70.08, for a total transaction of $708,088.32. Following the sale, the vice president now directly owns 87,400 shares of the company’s stock, valued at $6,124,992. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, VP Everett Neville sold 4,895 shares of Express Scripts stock in a transaction dated Thursday, March 1st. The stock was sold at an average price of $75.26, for a total value of $368,397.70. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 21,896 shares of company stock worth $1,617,903. 0.68% of the stock is currently owned by company insiders.
Several analysts recently issued reports on the company. BidaskClub lowered Express Scripts from a “buy” rating to a “hold” rating in a report on Wednesday. Sanford C. Bernstein lowered Express Scripts from a “market perform” rating to an “underperform” rating and raised their target price for the company from $55.80 to $77.50 in a report on Tuesday, January 30th. Raymond James Financial restated a “sell” rating on shares of Express Scripts in a report on Friday, December 15th. Jefferies Group set a $91.00 target price on Express Scripts and gave the company a “buy” rating in a report on Wednesday, February 28th. Finally, William Blair lowered Express Scripts from an “outperform” rating to a “market perform” rating in a report on Thursday, March 8th. Three equities research analysts have rated the stock with a sell rating, fourteen have given a hold rating and six have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $81.97.
Shares of Express Scripts Holding (ESRX) traded down $0.30 during trading hours on Wednesday, hitting $76.70. The stock had a trading volume of 8,366,125 shares, compared to its average volume of 6,260,000. The firm has a market capitalization of $43,220.00, a P/E ratio of 9.91, a P/E/G ratio of 0.96 and a beta of 0.94. Express Scripts Holding has a 12 month low of $55.80 and a 12 month high of $85.07. The company has a current ratio of 0.67, a quick ratio of 0.55 and a debt-to-equity ratio of 0.83.
Express Scripts (NASDAQ:ESRX) last issued its quarterly earnings results on Tuesday, February 27th. The company reported $2.16 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.09 by $0.07. The company had revenue of $25.38 billion for the quarter, compared to the consensus estimate of $25.07 billion. Express Scripts had a return on equity of 25.19% and a net margin of 4.51%. The firm’s revenue was up 2.1% compared to the same quarter last year. During the same period last year, the business posted $1.88 earnings per share. research analysts predict that Express Scripts Holding will post 9.35 EPS for the current fiscal year.
Express Scripts announced that its board has authorized a share repurchase program on Monday, December 18th that permits the company to buyback 45,000,000 outstanding shares. This buyback authorization permits the company to repurchase shares of its stock through open market purchases. Shares buyback programs are typically an indication that the company’s leadership believes its shares are undervalued.
Express Scripts Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.